Blocking HDAC6 with tubostation A or with compound 23BB significantly improved renal function and alleviated renal tubular injury in AKI models induced by rhabdomyolysis or cisplatin [18,20,21,25,26]. The gene discussed is HDAC6; the disease is rhabdomyolysis.